View Older Stories View More Recent Stories

Feb 14, 2023 05:21PM Form SC 13G/A VistaGen Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 05:17PM Form SC 13G Verastem, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 05:14PM Form SC 13G/A NeuroPace Inc Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 05:12PM Form SC 13G/A VectivBio Holding AG Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 05:08PM Form SC 13G/A Theravance Biopharma, Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 05:07PM Form SC 13G/A Sonendo, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 05:00PM Form SC 13G/A SI-BONE, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 04:58PM Form SC 13G/A Gracell Biotechnologies Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 04:56PM Form SC 13G/A Protara Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 04:56PM Form SC 13G/A RxSight, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 04:55PM Form SC 13G/A Jounce Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 04:47PM Form SC 13G/A Harpoon Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 04:46PM Form SC 13G Mersana Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 04:44PM Form SC 13G/A Mereo Biopharma Group Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 04:42PM Form SC 13G/A MeiraGTx Holdings plc Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 04:37PM Form SC 13G Kezar Life Sciences, Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 04:24PM Form SC 13G/A Applied Therapeutics Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 04:19PM Form SC 13G ALX ONCOLOGY HOLDINGS Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 04:17PM Form SC 13G/A Crinetics Pharmaceutical Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 04:14PM Form SC 13G/A CATALYST BIOSCIENCES, Filed by: ORBIMED ADVISORS LLC
Feb 14, 2023 04:13PM Form 13F-HR ORBIMED ADVISORS LLC For: Dec 31
Feb 14, 2023 04:03PM Form SC 13G/A Aeglea BioTherapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 7, 2023 09:00AM Garuda Therapeutics Secures $62 Million Series B Financing to Advance Off-the-Shelf Blood Stem Cell Technology Platform
Jan 26, 2023 04:41PM Form SC 13D/A 89bio, Inc. Filed by: ORBIMED ADVISORS LLC
Jan 20, 2023 09:26AM ADARx Pharmaceuticals Raises $46 Million as Lead Product Enters the Clinic
Jan 5, 2023 04:41PM Form SC 13D/A SpringWorks Therapeutics Filed by: ORBIMED ADVISORS LLC
Jan 4, 2023 08:00AM OnCusp Therapeutics Announces Appointment of Robert Forrester and Chau Khuong to Board of Directors
Jan 3, 2023 09:27PM Form 4 Disc Medicine, Inc. For: Dec 29 Filed by: ORBIMED ADVISORS LLC
Jan 3, 2023 09:23PM Form 3 Disc Medicine, Inc. For: Dec 29 Filed by: ORBIMED ADVISORS LLC
Jan 3, 2023 05:23PM Form SC 13D/A Disc Medicine, Inc. Filed by: ORBIMED ADVISORS LLC
Dec 29, 2022 08:30AM SINOVAC Reports Unaudited First Half of 2022 Financial Results
Dec 28, 2022 05:14PM Form SC 13D/A Terns Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Dec 27, 2022 05:39PM Form 4 Verona Pharma plc For: Dec 22 Filed by: ORBIMED ADVISORS LLC
Dec 27, 2022 04:37PM Form SC 13D/A Oric Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Dec 27, 2022 04:25PM Form SC 13D/A Verona Pharma plc Filed by: ORBIMED ADVISORS LLC
Nov 30, 2022 04:24PM Form SC 13D/A ARS Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Nov 30, 2022 08:06AM iECURE Raises $65 Million to Advance In Vivo Gene Editing Programs for the Treatment of Rare Pediatric Liver Diseases
Nov 29, 2022 04:27PM Form SC 13D/A scPharmaceuticals Inc. Filed by: ORBIMED ADVISORS LLC
Nov 25, 2022 08:14PM Form 4 Tricida, Inc. For: Nov 22 Filed by: ORBIMED ADVISORS LLC
Nov 25, 2022 04:58PM Form SC 13D/A Tricida, Inc. Filed by: ORBIMED ADVISORS LLC
Nov 17, 2022 10:00AM Scribe Therapeutics to Participate in Four Upcoming Conferences
Nov 14, 2022 04:12PM Form 13F-HR ORBIMED ADVISORS LLC For: Sep 30
Nov 10, 2022 04:27PM Form SC 13D/A Compass Therapeutics, Filed by: ORBIMED ADVISORS LLC
Nov 10, 2022 08:02AM Alpheus Medical Treats First Patients in First-In-Human Clinical Trial for Novel High-Grade Glioma Brain Cancer Treatment
Nov 8, 2022 04:04PM ARS Pharmaceuticals (SPRY) Closes Merger with Silverback Therapeutics (SBTX)
Nov 8, 2022 04:02PM ARS Pharmaceuticals Closes Merger with Silverback Therapeutics
Nov 8, 2022 04:02PM ARS Pharmaceuticals Closes Merger with Silverback Therapeutics
Nov 7, 2022 04:26PM Form SC 13D/A Keros Therapeutics, Inc. Filed by: ORBIMED ADVISORS LLC
Nov 1, 2022 08:30AM J.P. Morgan Launches New Life Sciences Private Capital Team Targeting Investments in Innovative Healthcare Companies
Oct 19, 2022 10:12AM PIC Therapeutics Completes $35 Million Series A Financing to Develop Treatments for Drug-Resistant Breast Cancer
View More Recent Stories View Older Stories